-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Smoking causes adverse outcomes in cancer patients: addressing the evidence base through efficient design
Graham W Warren
Commentary: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Elucidating the role of androgen receptor in breast cancer
Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomes: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation